CD4 and inflammatory bowel disease: CD4+ T cells are present at increased frequencies in inflamed tissue of patients with IBD, and a number of drugs targeting cytokines involved in CD4+ T cell differentiation into inflammatory subsets have shown clinical efficacy in treating IBD patients [124].